United States Pharmaceuticals

Baxalta Inc (BXLT)

Baxalta Inc. recorded its most recent insider trading activity on May 24, 2016. Historical data shows a mix of planned sales and acquisitions by various individuals earlier that year. Since these events occurred over three months ago, no current market performance context is provided regarding these historical transactions.
Ticker: BXLT Exchange: NYQ
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Devitt Blake E Non-Executive Director
Transaction date
Purchase
Price
277.12
Quantity 23,614
Value US$3,308,146
STROUCKEN ALBERT P L Non-Executive Director
Transaction date
Planned sale
Price
360.50
Quantity 19,003 +6.0%
Value US$2,115,037
FORSYTH JOHN D Non-Executive Director
Transaction date
Planned sale
Price
346.94
Quantity 95,949 +19.2%
Value US$4,903,914
GAVIN JAMES R III Non-Executive Director
Transaction date
Planned sale
Price
39.97
Quantity 5,660 -17.7%
Value US$226,230
Devitt Blake E Non-Executive Director
Transaction date
Purchase
Price
39.17
Quantity 5,900 +26.7%
Value US$231,103
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2016-05-26 2016-05-24 B Purchase Devitt Blake E Non-Executive Director
23,614
277.12
US$3,308,146 		23,614 277.12 US$3,308,146
2016-03-28 2016-03-24 PlS Planned sale STROUCKEN ALBERT P L Non-Executive Director
19,003 +6.0%
360.50
US$2,115,037 		19,003 +6.0% 360.50 US$2,115,037
2016-03-28 2016-03-24 PlS Planned sale FORSYTH JOHN D Non-Executive Director
95,949 +19.2%
346.94
US$4,903,914 		95,949 +19.2% 346.94 US$4,903,914
2016-03-28 2016-03-24 PlS Planned sale GAVIN JAMES R III Non-Executive Director
5,660 -17.7%
39.97
US$226,230 		5,660 -17.7% 39.97 US$226,230
2016-02-29 2016-02-25 B Purchase Devitt Blake E Non-Executive Director
5,900 +26.7%
39.17
US$231,103 		5,900 +26.7% 39.17 US$231,103
Explore more

More insider trading research around Baxalta Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America